Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Safety, tolerability, pharmacokinetics, and pharmacodynamics of JMKX003002 in single and multiple ascending dose randomized,doubled-blind phase 1 study in healthy subjects
Epistemonikos ID: 80d22fd425cc091e9cf96cc6beed6c6cf06c10e4
First added on: May 15, 2024